We are live on ! Find out more
MAM

Meeder Asset Management Portfolio holdings

AUM $1.75B
1-Year Est. Return 34.85%
This Fund
S&P 500
This Quarter Est. Return
+6.92%
1 Year Est. Return
+34.85%
3 Year Est. Return
+121.24%
5 Year Est. Return
+152.15%
10 Year Est. Return
+544.68%
AUM
$1.33B
AUM Growth
+$172M
Cap. Flow
+$108M
Cap. Flow %
8.1%
Top 10 Hldgs %
18.38%
Holding
1,833
New
283
Increased
650
Reduced
474
Closed
294

Top Sells

Rank Stock Value
1
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$17.3M
2
MA icon
Mastercard
MA
+$7.29M
3
ELV icon
Elevance Health
ELV
+$6.89M
4
BKNG icon
Booking.com
BKNG
+$6.27M
5
IBM icon
IBM
IBM
+$5.77M

Sector Composition

Rank Sector Weight
1 Technology 17%
2 Healthcare 14.77%
3 Financials 11.38%
4 Consumer Discretionary 8.43%
5 Industrials 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EOLS icon
1401
Evolus
EOLS
$475M
$3K ﹤0.01%
189
+140
+286% +$3.03K
ESSA
1402
DELISTED
ESSA Bancorp
ESSA
$3K ﹤0.01%
179
FTK icon
1403
Flotek Industries
FTK
$1.3B
$3K ﹤0.01%
+190
New +$2.94K
HBB icon
1404
Hamilton Beach Brands
HBB
$355M
$3K ﹤0.01%
134
-2
-1% -$51
HLX icon
1405
Helix Energy Solutions
HLX
$1.47B
$3K ﹤0.01%
+329
New +$3K
HSTM icon
1406
HealthStream
HSTM
$814M
$3K ﹤0.01%
95
-1,393
-94% -$41.7K
IOVA icon
1407
Iovance Biotherapeutics
IOVA
$2.77B
$3K ﹤0.01%
344
-1,068
-76% -$15.2K
JRVR icon
1408
James River Group Holdings
JRVR
$221M
$3K ﹤0.01%
69
MGTX icon
1409
MeiraGTx Holdings
MGTX
$1.19B
$3K ﹤0.01%
+191
New +$2.06K
OVID icon
1410
Ovid Therapeutics
OVID
$489M
$3K ﹤0.01%
626
+264
+73% +$2K
SGMO
1411
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$3K ﹤0.01%
151
-509
-77% -$7.74K
TOL icon
1412
Toll Brothers
TOL
$14.1B
$3K ﹤0.01%
100
-1,226
-92% -$44.4K
UONEK icon
1413
Urban One Class D
UONEK
$25.1M
$3K ﹤0.01%
136
-30
-18% -$635
VERI icon
1414
Veritone
VERI
$116M
$3K ﹤0.01%
+311
New +$4.11K
VIVS
1415
VivoSim Labs
VIVS
$1.15M
$3K ﹤0.01%
12
+3
+33% +$902
AINC
1416
DELISTED
Ashford Inc.
AINC
$3K ﹤0.01%
+45
New +$3.72K
BPTH
1417
DELISTED
Bio-Path Holdings Inc
BPTH
$3K ﹤0.01%
11
+4
+57% +$2.16K
PRTK
1418
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$3K ﹤0.01%
+333
New +$3.36K
ACGN
1419
DELISTED
Aceragen Inc
ACGN
$3K ﹤0.01%
21
+15
+250% +$2.14K
CHRA
1420
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$3K ﹤0.01%
+34
New +$2.73K
NE
1421
DELISTED
Noble Corporation
NE
$3K ﹤0.01%
+476
New +$2.89K
MFSF
1422
DELISTED
MutualFirst Financial Inc
MFSF
$3K ﹤0.01%
90
-189
-68% -$7.19K
PETX
1423
DELISTED
Aratana Therapeutics, Inc.
PETX
$3K ﹤0.01%
+574
New +$2.87K
INSY
1424
DELISTED
Insys Therapeutics, Inc.
INSY
$3K ﹤0.01%
337
+59
+21% +$471
TAX
1425
DELISTED
Liberty Tax, Inc. Class A
TAX
$3K ﹤0.01%
263
-42
-14% -$380

Similar funds

Meeder Asset Management's Q3 2018 Portfolio in Review

As of Q3 2018, Meeder Asset Management held 1,833 positions worth $1.33B, up 15% from $1.16B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Meeder Asset Management deployed $108M of net new capital in Q3 2018, opening 283 new positions and adding to 650 existing holdings. Its largest new stake was Humana: 24,758 shares worth $8.38M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares Core US Aggregate Bond ETF, an estimated $17.3M trimmed.

  • Meeder Asset Management's largest Q3 2018 buy was Humana: 24,758 shares worth $8.38M.
  • Meeder Asset Management added most to iShares JPMorgan USD Emerging Markets Bond ETF in Q3 2018, an estimated $15.6M increase.
  • Meeder Asset Management's biggest Q3 2018 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $17.3M.
  • Meeder Asset Management fully exited Centene in Q3 2018, selling an estimated $3.09M.
  • Meeder Asset Management's ten largest holdings make up 18% of its $1.33B portfolio in Q3 2018.
  • Meeder Asset Management opened 283 new positions and closed 294 in Q3 2018.
  • Meeder Asset Management's portfolio value rose 15% quarter-over-quarter to $1.33B.

Based on Meeder Asset Management's 13F filing for Q3 2018, filed 2 Nov 2018.